Healthcare provider profile · identity verified

Dennis E Mccreary

Family Practice · ZION, IL · NPI 1396720694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	908	255
Amlodipine Besylate	Amlodipine Besylate	752	214
Pantoprazole Sodium	Pantoprazole Sodium	462	145
Losartan Potassium	Losartan Potassium	457	134
Metoprolol Succinate	Metoprolol Succinate	433	118
Hydrochlorothiazide	Hydrochlorothiazide	405	108
Lisinopril	Lisinopril	405	113
Levothyroxine Sodium	Levothyroxine Sodium	394	103
Metformin Hcl	Metformin Hcl	313	93
Gabapentin	Gabapentin	288	72
Furosemide	Furosemide	282	79
Pregabalin	Pregabalin	244	42
Meloxicam	Meloxicam	219	49
Jardiance	Empagliflozin	195	44
Simvastatin	Simvastatin	182	48
Tamsulosin Hcl	Tamsulosin Hcl	161	43
Tramadol Hcl	Tramadol Hcl	159	32
Trazodone Hcl	Trazodone Hcl	159	44
Glipizide	Glipizide	158	42
Omeprazole	Omeprazole	153	45
Rosuvastatin Calcium	Rosuvastatin Calcium	142	42
Carvedilol	Carvedilol	137	43
Albuterol Sulfate Hfa	Albuterol Sulfate	135	42
Clopidogrel	Clopidogrel Bisulfate	133	33
Lorazepam	Lorazepam	130	24
Potassium Chloride	Potassium Chloride	112	31
Baclofen	Baclofen	107	36
Alendronate Sodium	Alendronate Sodium	96	31
Duloxetine Hcl	Duloxetine Hcl	96	22
Ozempic	Semaglutide	92	23
Vitamin D2	Ergocalciferol (Vitamin D2)	87	30
Sertraline Hcl	Sertraline Hcl	86	23
Metoprolol Tartrate	Metoprolol Tartrate	85	20
Allopurinol	Allopurinol	82	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	22
Montelukast Sodium	Montelukast Sodium	77	21
Atenolol	Atenolol	75	21
Oxybutynin Chloride Er	Oxybutynin Chloride	75	17
Azithromycin	Azithromycin	74	57
Donepezil Hcl	Donepezil Hcl	74	22
Escitalopram Oxalate	Escitalopram Oxalate	73	19
Alprazolam	Alprazolam	72	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	20
Meclizine Hcl	Meclizine Hcl	68	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	20
Diclofenac Sodium	Diclofenac Sodium	65	16
Azelastine Hcl	Azelastine Hcl	63	39
Xarelto	Rivaroxaban	61	15
Ezetimibe	Ezetimibe	60	17
Valsartan	Valsartan	60	17
Fluoxetine Hcl	Fluoxetine Hcl	57	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	13
Linzess	Linaclotide	56	14
Prednisone	Prednisone	56	31
Warfarin Sodium	Warfarin Sodium	55	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	54	42
Finasteride	Finasteride	54	11
Mounjaro	Tirzepatide	54	12
Citalopram Hbr	Citalopram Hydrobromide	53	16
Amitriptyline Hcl	Amitriptyline Hcl	52	15
Eliquis	Apixaban	52	15
Hydralazine Hcl	Hydralazine Hcl	52	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	suppressed
Paroxetine Hcl	Paroxetine Hcl	50	14
Pravastatin Sodium	Pravastatin Sodium	50	16
Fenofibrate	Fenofibrate	49	16
Celecoxib	Celecoxib	48	13
Synthroid	Levothyroxine Sodium	48	12
Metformin Hcl Er	Metformin Hcl	47	14
Aripiprazole	Aripiprazole	46	suppressed
Memantine Hcl	Memantine Hcl	45	suppressed
Bupropion Xl	Bupropion Hcl	43	11
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Valacyclovir	Valacyclovir Hcl	41	11
Mirtazapine	Mirtazapine	39	12
Doxycycline Hyclate	Doxycycline Hyclate	38	21
Fluticasone Propionate	Fluticasone Propionate	37	16
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Famotidine	Famotidine	36	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	11
Triamcinolone Acetonide	Triamcinolone Acetonide	36	21
Diazepam	Diazepam	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	12
Pioglitazone Hcl	Pioglitazone Hcl	34	12
Propranolol Hcl	Propranolol Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	12
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Midodrine Hcl	Midodrine Hcl	33	suppressed
Sucralfate	Sucralfate	32	11
Temazepam	Temazepam	32	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Cephalexin	Cephalexin	29	24
Glipizide Er	Glipizide	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	25
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	27	suppressed
Methylprednisolone	Methylprednisolone	27	26
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	11
Enalapril Maleate	Enalapril Maleate	25	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Colchicine	Colchicine	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Topiramate	Topiramate	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Ketoconazole	Ketoconazole	23	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	19
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Primidone	Primidone	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Amoxicillin	Amoxicillin	15	12
Chlorthalidone	Chlorthalidone	15	suppressed
Minoxidil	Minoxidil	15	suppressed
Tiotropium Bromide	Tiotropium Bromide	15	suppressed
Clonidine	Clonidine	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Dalfampridine Er	Dalfampridine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error